# Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)

> **NCT01702506** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** dacomitinib fasted
- **DRUG:** dacomitinib fed
- **DRUG:** dacomitinib+antacid

## Key facts

- **NCT ID:** NCT01702506
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01702506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01702506, "Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01702506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*